Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0G9WE
|
|||
Former ID |
DIB018944
|
|||
Drug Name |
batrachotoxin
|
|||
Synonyms |
BATRACHOTOXIN; UNII-TSG6XHX09R; TSG6XHX09R; Batrachotoxinin A, 20-(2,4-dimethyl-1H-pyrrole-3-carboxylate); Betrachotoxinin A, 20-alpha-(2,4-dimethyl-1H-pyrrole-3-carboxylate); 23509-16-2; GTPL2619; LS-24727; Betrachotoxinin A, 20-alpha-(2,4-dimethyl-1H-pyrrole-3-carboxylate) (9CI)
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL
|
|||
Formula |
C31H42N2O6
|
|||
Canonical SMILES |
CC1=CNC(=C1C(=O)OC(C)C2=CCC34C2(CC(C56C3=CCC7C5(CCC(C7)(O6)O)C)O)CN(CCO4)C)C
|
|||
InChI |
1S/C31H42N2O6/c1-18-16-32-19(2)25(18)26(35)38-20(3)22-8-9-30-23-7-6-21-14-29(36)11-10-27(21,4)31(23,39-29)24(34)15-28(22,30)17-33(5)12-13-37-30/h7-8,16,20-21,24,32,34,36H,6,9-15,17H2,1-5H3/t20-,21+,24+,27-,28-,29+,30-,31-/m0/s1
|
|||
InChIKey |
ISNYUQWBWALXEY-OMIQOYQYSA-N
|
|||
CAS Number |
CAS 23509-16-2
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | SCN1A messenger RNA (SCN1A mRNA) | Target Info | Activator | [2] |
Voltage-gated sodium channel alpha Nav1.2 (SCN2A) | Target Info | Activator | [3] | |
Voltage-gated sodium channel alpha Nav1.3 (SCN3A) | Target Info | Activator | [4] | |
Voltage-gated sodium channel alpha Nav1.4 (SCN4A) | Target Info | Activator | [5] | |
Voltage-gated sodium channel alpha Nav1.5 (SCN5A) | Target Info | Activator | [6] | |
Voltage-gated sodium channel alpha Nav1.6 (SCN8A) | Target Info | Activator | [7] | |
Voltage-gated sodium channel alpha Nav1.7 (SCN9A) | Target Info | Activator | [8] | |
Voltage-gated sodium channel alpha Nav1.8 (SCN10A) | Target Info | Activator | [9] | |
KEGG Pathway | Dopaminergic synapse | |||
Adrenergic signaling in cardiomyocytes | ||||
Pathwhiz Pathway | Muscle/Heart Contraction | |||
Reactome | Interaction between L1 and Ankyrins | |||
WikiPathways | SIDS Susceptibility Pathways | |||
Cardiac Progenitor Differentiation |
References | Top | |||
---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2619). | |||
REF 2 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 578). | |||
REF 3 | Interaction of batrachotoxin with the local anesthetic receptor site in transmembrane segment IVS6 of the voltage-gated sodium channel. Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13947-52. | |||
REF 4 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 580). | |||
REF 5 | Point mutations in segment I-S6 render voltage-gated Na+ channels resistant to batrachotoxin. Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2653-8. | |||
REF 6 | Binding of [3H]batrachotoxinin A benzoate to specific sites on rat cardiac sodium channels. Mol Pharmacol. 1986 Dec;30(6):617-23. | |||
REF 7 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 583). | |||
REF 8 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 584). | |||
REF 9 | The poison Dart frog's batrachotoxin modulates Nav1.8. FEBS Lett. 2004 Nov 5;577(1-2):245-8. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.